Cataract Therapeutics

Novel dexamethasone formulation shows efficacy and safety with once-daily use

September 01, 2020

A vehicle-controlled phase 2 study investigating once- and twice-daily administration of a novel, preservative-free topical formulation of dexamethasone as treatment for pain and inflammation after cataract surgery met its primary endpoints.